Establishment Labs’s $76.9 Million Initial Public Offering


Wilson Sonsini Goodrich & Rosati represented Establishment Labs in the offering


Establishment Labs, a global medical technology company focused on breast aesthetics and reconstruction technologies, announced the closing of its initial public offering of 4,272,568 common shares at a public offering price of $18.00 per share, which includes the full exercise of the underwriters’ option to purchase 557,291 additional shares. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Establishment Labs, were approximately $76.9 million. The shares began trading on the Nasdaq Capital Market under the ticker symbol “ESTA” on July 19.

Jefferies and Cowen and Company acted as the joint book-running managers for the offering, while BTIG acted as the lead manager for the offering.

The WSGR advised Establishment Labs with Elton Satusky (Picture), Jesse Schumaker, Drew Morris, RJ Lang, Joan Moses (Capital Markets), Scott McCall, Mark Cornillez-Ty (Employee Benefits and Compensation), Lowell Segal, Alex Key (Technology Transactions) and Myra Sutanto Shen (Tax).

Involved fees earner: Elton Satusky – Wilson Sonsini Goodrich & Rosati; Jesse Schumaker – Wilson Sonsini Goodrich & Rosati; Drew Morris – Wilson Sonsini Goodrich & Rosati; RJ Lang – Wilson Sonsini Goodrich & Rosati; Scott McCall – Wilson Sonsini Goodrich & Rosati; Mark Cornillez-Ty – Wilson Sonsini Goodrich & Rosati; Lowell Segal – Wilson Sonsini Goodrich & Rosati; Alexander Key – Wilson Sonsini Goodrich & Rosati; Myra Sutanto Shen – Wilson Sonsini Goodrich & Rosati;

Law Firms: Wilson Sonsini Goodrich & Rosati;

Clients: Establishment Labs Holdings Inc;

Avatar

Author: Ambrogio Visconti